Iran War: Trump Wavers On Escalation as US Pump Price Tops $4 | The Pulse 3/31

The episode of "The Pulse With Francine Lacqua" features Grace Peters (JPMorgan Private Bank, Global Investment Strategy Co‑Head), Silvia Viviano (UniCredit, Head of Equity Capital Markets), Darya Dolzikova (RUSI, Proliferation and Nuclear Policy Senior Fellow) and Diana Choyleva (Enodo Economics, Chief Economist). Expect discussion on private bank asset allocation and investor positioning, equity capital markets and IPO activity, geopolitical risks around proliferation and sanctions, and macro outlook including economic data and monetary policy; this is informational commentary with limited near-term market impact.

Analysis

Private-bank client flows are quietly re-shaping market microstructure: assigned cash buffers and higher allocations to private credit/illiquids mean recurring fee revenue for large asset managers will be stickier than headline equity flows imply. That mechanically favors firms with large private-credit franchises (faster AUM-to-fee conversion) and exchanges/ECM desks when the backlog of deals clears, creating a concentrated positive earnings surprise risk for those incumbents over the next 3–12 months.

Geopolitical friction and sanctions continue to skew capital spending: procurement cycles for defense, nuclear and dual‑use supply chains lengthen, benefitting OEMs with backlog visibility while squeezing small, just‑in‑time suppliers and re-insurers exposed to trade finance. Expect orderbook-driven revenue to show up on quarterly reports in 6–18 months, and capex to be lumpy — this is not a single‑day repricing but a multi‑quarter rerating as firms win multi‑year contracts.

Key tail risks are binary: de‑escalation would remove a major demand pillar for defense/nuclear exposure and precipitate a near-term pullback (days–weeks), while a sharp macro softening or rapid Fed pivot would reroute private client flows back into duration and cash (months). The consensus trades favor large defense primes and commodity miners; contrarian opportunity lies in owners of execution/ECM infrastructure and select nuclear services/miners whose earnings are underappreciated given the expected deal and capex cadence over 3–12 months.

Key Decisions for Investors

• Long BX (Blackstone) — initiate 2% portfolio exposure via shares or 12‑month call spread to cap cost. Thesis: private credit fee growth and preferred-fee pools to deliver +20–30% EPS upside in 9–12 months; downside limited to ~15% if credit markets reprice sharply.
• Long CCJ (Cameco) — buy 12‑month calls (or 1–1.5% position in spot if risk appetite higher). Thesis: nuclear fuel cycle tightening and order visibility supports >30% upside over 6–12 months; tail risk of >20% on swift policy reversal or uranium price drop.
• Long LSEG (London Stock Exchange Group) — 6–12 month position sized 1–2% portfolio: benefits from an IPO/ECM catch‑up once volatility normalizes. Risk/reward: asymmetric upside (20–40%) if ECM activity resumes, modest downside (~15%) if IPO drought persists.
• Tactical pair: long BWXT (small/mid nuclear services supplier) vs short a large defense prime (e.g., NOC) — size 0.5–1% net long exposure. Rationale: BWXT benefits earlier from civilian nuclear capex and specialized services with less political procurement risk; pair reduces broad defense-policy tail risk. Target spread capture 15–25% over 6–12 months, with stop-loss if spread widens >20%.